ORIC-533

CAT: 0804-HY-160696Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-160696Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ORIC-533 is an orally active, selective CD73 inhibitor with AMP-competition. ORIC-533 restores immunosuppressed CD8+ T cell proliferation and activation, triggers significant lysis and cell death of multiple myeloma cells in the bone marrow microenvironment[1].
CAS Number
[2641306-62-7]
UNSPSC
12352005
Target
CD73
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/oric-533.html
Solubility
10 mM in DMSO
Smiles
O[C@H]1[C@@H](O)[C@H](N2C3=NC(Cl)=NC(NC4CCCC4)=C3C=N2)O[C@@H]1CO[C@](P(O)(O)=O)(CO)COCC5=NN=NN5
Molecular Formula
C20H29ClN9O9P
Molecular Weight
605.93
References & Citations
[1]Junttila M R, et al., ORIC-533, a small molecule CD73 inhibitor with best-in-class properties, reversesimmunosuppression and has potential as an immunomodulatory therapy in patients with multiple myeloma[J]. Cancer Research, 2022, 82 (12_Supplement) : 2074-2074.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1

Related Products

CatalogName
HY-112710-01ORIC-101
HY-148877-01AT-533
HY-138188-01KRA-533
HY-W953639CRBN ligand-533
HY-P1199-01Pp60 c-src (521-533) (phosphorylated)
HY-P84624-01Phospho-NLRC4 (Ser-533) Antibody (YA4321, Rat)
HY-P84625-01Phospho-NLRC4 (Ser-533) Antibody (YA4322, Rat)
HY-157226ORI-TRN-002
HY-108044-01ONO-5334
HY-152520RLA-5331

Alternative Products

CatalogName
MF-0121089-01ORIC-533
BUP18629-01ORIC-944
BA5995-1ORIC-101
MF-0063398-01AT-533
MF-0122099-01ORIC-944 TFA
A19587-1ORIC-101 1mg
A19587-5ORIC-101 5mg
A19587-25ORIC-101 25mg
A19587-100ORIC-101 100mg
A19587-10ORIC-101 10mg

Popular Products